Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Human Gene Therapy|August 11, 2017
Making Oncolytic Virotherapy a Clinical Reality: The European ContributionMargaret R Duffy, Kerry D Fisher, Len W SeymourNanomedicine (London, England)|February 21, 2012
Manipulation of adenovirus interactions with host factors for gene therapy applicationsMargaret R Duffy, Alan L Parker, Angela C Bradshaw, et al.Journal of Virology|August 19, 2011
A cluster of basic amino acids in the factor X serine protease mediates surface attachment of adenovirus/FX complexesMargaret R Duffy, Angela C Bradshaw, Alan L Parker, et al.Macromolecular Bioscience|September 14, 2017
Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic VirusesEleanor M Scott, Margaret R Duffy, Joshua D Freedman, et al.Nature Communications|March 8, 2022
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contaminationWeiheng Su, Maria I Patrício, Margaret R Duffy, et al.The Journal of General Virology|May 19, 2016
Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loopStacy Robertson, Alan L Parker, Carolyn Clarke, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 25, 2013
Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approachMargaret R Duffy, Alan L Parker, Eric R Kalkman, et al.Plos Pathogens|October 16, 2010
Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor XAngela C Bradshaw, Alan L Parker, Margaret R Duffy, et al.Journal of Virology|April 7, 2017
Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction In Vitro in the Presence of Mouse SerumEstrella Lopez-Gordo, Andor Doszpoly, Margaret R Duffy, et al.Molecular Therapy Oncolytics|May 9, 2017
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic AdenovirusSam Illingworth, Ying Di, Maxine Bauzon, et al.Pageof 2